Radiosynthesis, In Vitro and In Vivo Evaluation of [18F]CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-Tauopathies-Reference-Cited by-同舟云学术

Radiosynthesis, In Vitro and In Vivo Evaluation of [18F]CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-Tauopathies

Published:2021-01-26 Issue:4 Volume:12 Page:596-602
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Lindberg Anton¹,Knight Ashley C.¹²^ORCID,Sohn Daniel³⁴,Rakos Laszlo³⁴,Tong Junchao¹,Radelet April⁵,Mason N. Scott⁵^ORCID,Stehouwer Jeffrey S.⁵,Lopresti Brian J.⁵,Klunk William E.⁶,Sandell Johan⁴,Sandberg Alexander⁷,Hammarström Per⁷,Svensson Samuel³⁷,Mathis Chester A.⁵,Vasdev Neil¹²^ORCID

Affiliation:

1. Azrieli Centre for Neuro-Radiochemistry, Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON M5T 1R8, Canada

2. Department of Psychiatry/Institute of Medical Science, University of Toronto, Toronto, ON M5T 1R8, Canada

3. CBD Solutions, Center for Molecular Medicine, Karolinska Hospital, SE-17176 Stockholm, Sweden

4. Novandi Chemistry AB, SE-15136 Södertälje, Sweden

5. Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, United States

6. Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, United States

7. Department of Physics, Chemistry and Biology, Linköping University, SE-58183 Linköping, Sweden

Funder

Center for Scientific Review

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.0c00801

Reference30 articles.

1. Oligomerization of the microtubule‐associated protein tau is mediated by its N‐terminal sequences: implications for normal and pathological tau action

2. Structural Polymorphism of 441-Residue Tau at Single Residue Resolution

3. Tau Conformation as a Target for Disease-Modifying Therapy: The Role of Truncation

4. Chronic Traumatic Encephalopathy in Athletes: Progressive Tauopathy After Repetitive Head Injury

5. Specific Pathological Tau Protein Variants Characterize Pickʼs Disease

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Bifunctional Dimer Caffeine-Indan Attenuates α-Synuclein Misfolding, Neurodegeneration and Behavioral Deficits after Chronic Stimulation of Adenosine A1 Receptors;International Journal of Molecular Sciences;2024-08-29

2. Diagnosis and Management of Progressive Corticobasal Syndrome;Current Treatment Options in Neurology;2024-06-25

3. Ligand-based design of [18F]OXD-2314 for PET imaging in non-Alzheimer’s disease tauopathies;Nature Communications;2024-06-14

4. In vitro evaluation of [3H]PI-2620 and structural derivatives in non-Alzheimer's tauopathies;Nuclear Medicine and Biology;2024-03

5. New Perspectives in Radiological and Radiopharmaceutical Hybrid Imaging in Progressive Supranuclear Palsy: A Systematic Review;Cells;2023-12-06